Circulating immune cell phenotype can predict the outcome of lenalidomide plus low-dose dexamethasone treatment in patients with refractory/relapsed multiple myeloma
- Sung Eun Lee
- , Ji Young Lim
- , Da Bin Ryu
- , Tae Woo Kim
- , Jae Ho Yoon
- , Byung Sik Cho
- , Ki Seong Eom
- , Yoo Jin Kim
- , Hee Je Kim
- , Seok Lee
- , Seok Goo Cho
- , Dong Wook Kim
- , Jong Wook Lee
- , Woo Sung Min
- , Myungshin Kim
- , Chang Ki Min
Research output: Contribution to journal › Article › peer-review
22
Scopus
citations